President directs CMMI to consider new models to lower drug costs
President Biden today directed the Center for Medicare and Medicaid Innovation to consider new payment and delivery models to lower drug costs and promote access to innovative drug therapies for beneficiaries, and report within 90 days on its plan and timeline for testing selected models. AHA will update members as more information on the plan becomes available.
Related News Articles
Headline
Health care experts and leaders from across the country presented sessions that offered conference attendees practical and adaptable solutions to issues such…
Headline
Michelle Hood, AHA executive vice president and COO, and Bill Gassen, president and CEO of Sanford Health in Sioux Falls, S.D., and chair-elect designate of…
Headline
Capitol Hill was the focus of the second morning of the AHA 2026 Rural Health Care Leadership Conference, taking place through tomorrow in…
Headline
The AHA Feb. 10 released its 2026 Rural Advocacy Agenda, laying out the association's key priorities for Congress, the administration, regulatory agencies and…
Headline
The 5th U.S. Circuit Court of Appeals Feb. 9 affirmed a district court ruling upholding Louisiana’s 340B contract pharmacy law. The state law prohibits…
Chairperson's File
All hospital and health system leaders are committed to delivering the best possible care to the people we serve while navigating the changes and challenges we…